A multi-centre, randomised, controlled, double-blind, parallel-group study on the efficacy and safety of Pennsaid-2% topical skin solution in patients with Grade I-II ankle sprain

Trial Profile

A multi-centre, randomised, controlled, double-blind, parallel-group study on the efficacy and safety of Pennsaid-2% topical skin solution in patients with Grade I-II ankle sprain

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Jun 2017

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Sprains
  • Focus Therapeutic Use
  • Sponsors Nuvo Pharmaceuticals
  • Most Recent Events

    • 23 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 15 May 2017 Results published in a Nuvo Pharmaceuticals media release.
    • 15 May 2017 Primary endpoint (Reduction in pain on movement (POM) at day 3 (D01-adjusted estimate).) has been met, according to a Nuvo Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top